Home/Filings/4/0001140361-22-029132
4//SEC Filing

Diwan Anil 4

Accession 0001140361-22-029132

CIK 0001379006other

Filed

Aug 9, 8:00 PM ET

Accepted

Aug 10, 6:51 PM ET

Size

5.0 KB

Accession

0001140361-22-029132

Insider Transaction Report

Form 4
Period: 2022-08-08
Diwan Anil
DirectorPresident10% Owner
Transactions
  • Gift

    Common Stock, par value $0.001 per share

    2022-08-0894,4710 total
Footnotes (3)
  • [F1]The reported transaction involves a gift made by the reporting person for estate planning purposes to an irrevocable trust whose beneficiaries are his minor children and of which he is neither the trustee nor a beneficiary.
  • [F2]Does not include 6,074 shares of Series A Convertible Preferred Stock (the "Series A Stock") owned by the reporting person which is convertible into three and one-half shares of common stock upon limited conditions.
  • [F3]Does not include 200,000 shares of Series A Stock or 470,959 shares of common stock owned by TheraCour Pharma, Inc., over which the reporting person holds voting and dispositive power.

Issuer

NANOVIRICIDES, INC.

CIK 0001379006

Entity typeother

Related Parties

1
  • filerCIK 0001513285

Filing Metadata

Form type
4
Filed
Aug 9, 8:00 PM ET
Accepted
Aug 10, 6:51 PM ET
Size
5.0 KB